SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (6323)11/19/1998 9:46:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Canada Issues Viagra Rule
Thursday November 19 12:38 PM ET

TORONTO (AP) - The Canadian government has told its workers it won't cover them for the costs of using Viagra, fearing demand for the impotency drug might bankrupt the federal health plan.

About one million civil servants who are covered by the plan were notified of the decision by the Treasury Board.

Viagra is expected to be approved for use in Canada by the end of the year, the National Post reported Thursday.

The drug debuted in the United States in April and has been in high demand since. It is expected to have a similar reception in Canada.



To: Anthony Wong who wrote (6323)11/19/1998 9:50:00 PM
From: Anthony Wong  Respond to of 9523
 
National Post (Canada):Civil servants won't get free Viagra, Threat to health plan
Thursday, November 19, 1998



Brad Evenson
National Post

The federal government has told its employees it will not pay for
Viagra, the anti-impotence drug. The anticipated demand is so
great that actuaries fear it could bankrupt the country's largest
health plan.

"In the United States, Viagra has been the fastest selling drug in
history," a bulletin says.

Effective immediately, it states, the Treasury Board has decided not
to cover the drug when it is approved in Canada. Approval is
expected before Christmas.

Roughly one million people are covered by the plan, including
RCMP officers and military personnel. It paid $256.6-million in
medical benefits last year.

The decision is part of a consensus among health insurers against
covering new "lifestyle" drugs, including medications for baldness,
obesity and even shyness.

According to William M. Mercer Ltd., a human-resources
consulting company, Canada has a potential 3.6 million customers
for Viagra, although less than one in 10 is likely to seek treatment.

Insurers typically pay $300 to $500 per client for prescription
drugs.

Viagra is expected to cost $14 a pill, and a normal monthly
prescription is eight to 10 pills. That would bring the annual tab to
$1,680, excluding pharmacy dispensing fees.

"If the (government plan) were to cover Viagra, this would likely
result in plan changes potentially affecting all members," said the
memo, promising to review the decision at a later date.

nationalpost.com



To: Anthony Wong who wrote (6323)12/11/1998 8:58:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 9523
 
Today's WSJ has an extensive article on the 55% reduction in breast cancer among patients taking LLY's Evista (Raloxifene). The article also discusses patent expirations. Details linked to the New Therapeutics page of biocognizance.com (SERM Table)
PFE has begun a breast cancer prevention trial with their most advanced SERM (Droloxifene) and they have another SERM (CP-366,156) in trials. Details linked to Ligand Clinical Trials page.